home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

4.030 +0.360 (+9.81%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference

April 10, 2023

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

April 03, 2023

From Enveric Biosciences, Inc.

Via Business Wire

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

Via Benzinga

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

Via Benzinga

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

March 23, 2023

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications

March 21, 2023

From Enveric Biosciences

Via Business Wire

Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program ↗

March 21, 2023

Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics...

Via Benzinga

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme ↗

March 14, 2023

Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a...

Via Benzinga

Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery

March 14, 2023

From Enveric Biosciences

Via Business Wire

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗

March 13, 2023

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

Via Benzinga

Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person ↗

March 08, 2023

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established...

Via Benzinga

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗

March 06, 2023

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

Via Benzinga

Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 28, 2023

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 23, 2023

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference

February 22, 2023

From Enveric Biosciences

Via Business Wire

The 7 Most Promising Psychedelic Stocks to Buy in February ↗

February 05, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Via InvestorPlace

Enveric Biosciences to Present at the BIO CEO & Investor Conference

February 01, 2023

From Enveric Biosciences

Via Business Wire

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways ↗

January 03, 2023

What a year for psychedelics!

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 21, 2022

Via Benzinga

Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"

December 21, 2022

From Enveric Biosciences

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 08, 2022

Via Benzinga

Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders

November 28, 2022

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference

November 16, 2022

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022

November 01, 2022

From Enveric Biosciences

Via Business Wire

15 Global Psychedelics Executives To Keep An Eye On In 2022 ↗

October 28, 2022

As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...

Via Benzinga

Enveric Biosciences Advances Lead Candidate for the Treatment of Anxiety Disorders to IND-Enabling Studies

October 24, 2022

From Enveric Biosciences Inc.

Via Business Wire

Enveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference

October 12, 2022

From Enveric Biosciences

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 29, 2022

Gainers

Via Benzinga

Psychedelics May Make People Less Afraid of Death

September 07, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change...

Via FinancialNewsMedia

Topics Supply Chain

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com